Patents by Inventor Michael Stephen Roberts
Michael Stephen Roberts has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20200000707Abstract: The present invention relates generally to therapeutic formulations. More particularly, this present invention provides an oral delivery system for a therapeutic compound that is a base, a salt of a base or an amphoteric compound or a salt of a amphoteric compound with pharmacological, physiological or biochemical activity or a proactive form thereof. The present invention even more particularly provides a swallow formulation comprising a therapeutic compound that is a base, a salt of a base, an amphoteric compound or a salt of an amphoteric compound which facilitates the rapid delivery of the therapeutic compound to the circulatory system.Type: ApplicationFiled: September 13, 2019Publication date: January 2, 2020Inventors: Michael Stephen Roberts, Mantu Sarkar, George Alexander Davidson, Ruoying Jiang, Geraldine Ann Elliott, Keivan Bezanehtak, Stephen Douglas Chandler, Gregory Davey
-
Patent number: 9757455Abstract: The present invention provides an oral delivery system for a therapeutic compound that is an acid, a salt of an acid or an unionized compound or a proactive form thereof with pharmacological, physiological or biochemical activity. The present invention particularly provides a swallow formulation comprising a therapeutic compound that is an acid, a salt of an acid or an unionized compound or a proactive form thereof which facilitates the rapid delivery of the therapeutic compound to the circulatory system.Type: GrantFiled: November 28, 2006Date of Patent: September 12, 2017Assignee: Johnson & Johnson Consumer Inc.Inventors: Michael Stephen Roberts, George Alexander Davidson, Ruoying Jiang, Geraldine Ann Elliott, Keivan Bezanehtak, Stephen Douglas Chandler, Greg Davey, Mantu Sarkar
-
Publication number: 20130065885Abstract: The present invention relates generally to therapeutic formulations. More particularly, this present invention provides an oral delivery system for a therapeutic compound that is a base, a salt of a base or an amphoteric compound or a salt of a amphoteric compound with pharmacological, physiological or biochemical activity or a proactive form thereof. The present invention even more particularly provides a swallow formulation comprising a therapeutic compound that is a base, a salt of a base, an amphoteric compound or a salt of an amphoteric compound which facilitates the rapid delivery of the therapeutic compound to the circulatory system.Type: ApplicationFiled: September 14, 2012Publication date: March 14, 2013Applicant: IMAGINOT PTY LTD.Inventors: Michael Stephen Roberts, Ruoying Jiang, Keivan Bezanehtak, Greg Andrew Davey, George Alexander Davidson, Geraldine Ann Elliott, Stephen Douglas Chandler, Mantu Sarkar
-
Patent number: 8216610Abstract: The present invention relates generally to formulations comprising paracetamol. More particularly, the present invention provides a swallow formulation comprising paracetamol which facilitates the rapid delivery of paracetamol into the circulatory system following oral administration. The present invention further relates to methods for inducing efficient pain relief including an analgesic effect by the administration of the paracetamol formulation.Type: GrantFiled: November 27, 2006Date of Patent: July 10, 2012Assignee: Imaginot Pty Ltd.Inventors: Michael Stephen Roberts, Ruoying Jiang, Keivan Bezanehtak, Greg Andrew Davey, George Alexander Davidson, Geraldine Ann Elliott, Stephen Douglas Chandler, Mantu Sarkar
-
Publication number: 20090311327Abstract: The present, invention provides an oral delivery system for a therapeutic compound that is an acid, a salt of an acid or an unionized compound or a proactive form thereof with pharmacological, physiological or biochemical activity. The present invention particularly provides a swallow formulation comprising a therapeutic compound that is an acid, a salt of an acid or an unionized compound or a proactive form thereof which facilitates the rapid delivery of the therapeutic compound to the circulatory system.Type: ApplicationFiled: November 28, 2006Publication date: December 17, 2009Applicant: IMAGINOT PTY LTDInventors: Michael Stephen Roberts, George Alexander Davidson, Ruoying Jiang, Geraldine Ann Elliott, Keivan Bezanehtak, Stephen Douglas Chandler, Greg Davey, Mantu Sarkar
-
Publication number: 20080287456Abstract: The present invention relates generally to therapeutic formulations. More particularly, this present invention provides an oral delivery system for a therapeutic compound that is a base, a salt of a base or an amphoteric compound or a salt of a amphoteric compound with pharmacological, physiological or biochemical activity or a proactive form thereof. The present invention even more particularly provides a swallow formulation comprising a therapeutic compound that is a base, a salt of a base, an amphoteric compound or a salt of an amphoteric compound which facilitates the rapid delivery of the therapeutic compound to the circulatory system.Type: ApplicationFiled: May 27, 2005Publication date: November 20, 2008Applicant: IMAGINOT PTY LTDInventors: Michael Stephen Roberts, Ruoying Jiang, Keivan Bezanehtak, Greg Davey, George Alexander Davidson, Geraldine Ann Elliott, Stephen Douglas Chandler, Mantu Sarkar
-
Patent number: 6909012Abstract: O-medium alkyl esters of diflunisal and related compounds are disclosed having anti-platelet activity, hydroxy radical scavenging properties, enhanced hepatic clearance and low ulcerogenic potential. These compounds have general formula (I) wherein n equals 3-13.Type: GrantFiled: December 27, 2002Date of Patent: June 21, 2005Assignee: University of QueenslandInventors: Daniel Yung-Yu Hung, Michael Stephen Roberts
-
Publication number: 20030220497Abstract: O-medium alkyl esters of diflunisal and related compounds are disclosed having anti-platelet activity, hydroxy radical scavenging properties, enhanced hepatic clearance and low ulcerogenic potential. These compounds have general formula (I) wherein n equals 3-13.Type: ApplicationFiled: December 27, 2002Publication date: November 27, 2003Applicant: The University of QueenslandInventors: Daniel Yung-Yu Hung, Michael Stephen Roberts
-
Patent number: 6593365Abstract: O-medium alkyl esters of diflunisal and related compounds are disclosed having anti-platelet activity, hydroxy radical scavenging properties, enhanced hepatic clearance and low ulcerogenic potential. These compounds have general formula (I) wherein n equals 3-13.Type: GrantFiled: October 12, 1999Date of Patent: July 15, 2003Assignee: The University of QueenslandInventors: Daniel Yung-Yu Hung, Michael Stephen Roberts
-
Patent number: 6001088Abstract: An iontophoresis method for delivenng an active substance or drug to a target tissue which includes the step of sandwiching the target tissue between a donor electrode and receptor electrode which are each electrically connnected to a power source wherein a current path between the donor electrode and the receptor electrode is maintained at a minimum value to enhance delivery of the active substance to the target tissue.Type: GrantFiled: August 18, 1997Date of Patent: December 14, 1999Assignee: The University of QueenslandInventors: Michael Stephen Roberts, Sheree Elizabeth Cross, Pam Muhtze Lai, Lawrence William Hirst
-
Patent number: 5820302Abstract: A method of stabilizing soil and aggregate for structural purposes including the step of mixing with water: (a) a soil aggregate base material; (b) a stabilization composition comprising: (i) an alkali metal silicate or other suitable gel precursor, and (ii) optionally a cation; and (c) a minimum amount of 1% of cement based on the weight of the resulting mixture, whereby sufficient water is added to the resulting mixture to hydrate the cement and thereby provide a stabilized soil aggregate matrix suitable for use in a structure.Type: GrantFiled: October 21, 1996Date of Patent: October 13, 1998Assignee: AD-Base Pty Ltd.Inventors: Michael Stephen Roberts, Peter Atkinson, Nicholas James Calos, David Lethbridge Oliver
-
Patent number: 5750141Abstract: A vaso-active agent is administered in combination with a therapeutic agent which is useful in treatment of tissue of the body which is located below the stratum corneum or the outermost layer of the epidermis, wherein the vaso-active agent may be administered by a local, topical or transdermal route to a particular site and the therapeutic agent may be administered in a similar manner in combination with the vaso-active agent or may be administered separately, wherein the vaso-active agent and the therapeutic agent for topical and/or transdermal administration may be provided in the form of a composition so as to increase local perfusion and/or concentration of the therapeutic agent at or adjacent an administration site of the vaso-active agent.Type: GrantFiled: December 4, 1995Date of Patent: May 12, 1998Assignee: The University of QueenslandInventors: Michael Stephen Roberts, Sheree Elizabeth Cross, Parminder Singh